Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.
June 08, 2022
Share
Amcare Lab announced that it has received $31,000,000 in a round of funding led by CICC Capital Management Co., Ltd. on June 9, 2022. The transaction included participation from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, and Bison Capital Asset Management, LLC.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.
JOINTOWN PHARMACEUTICAL GROUP CO., LTD 
